Abdominally non-obese (n = 1057) | ||||||
 Type 2 diabetes cases (n = 91) | ||||||
  Continuous Adipokines | Model 1†| Model 2‡ | ||||
HR | 95% CI | P | HR | 95% CI | P | |
   Log Plasma leptin (ng/mL) | 1.55 | (1.02, 2.36) | 0.04 | 0.92 | (0.58, 1.45) | 0.73 |
   Log Plasma adiponectin (ng/mL) | 0.86 | (0.60, 1.23) | 0.40 | 1.18 | (0.80, 1.73) | 0.41 |
Abdominally obese (n = 1599) | ||||||
 Type 2 diabetes cases (n = 364) | ||||||
  Continuous Adipokines | Model 1†| Model 2‡ | ||||
HR | 95% CI | p | HR | 95% CI | P | |
   Log Plasma leptin (ng/mL) | 1.04 | (0.81, 1.34) | 0.75 | 0.82 | (0.63, 1.07) | 0.14 |
   Log Plasma adiponectin (ng/mL) | 0.53 | (0.44, 0.63) | <.0001 | 0.66 | (0.54, 0.80) | <.0001 |